Alnylam Pharmaceuticals, Inc is a company in the U.S. stock market and it is a holding in 85 U.S.-traded ETFs. ALNY has around 7.6M shares in the U.S. ETF market. The largest ETF holder of ALNY is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 1.05M shares. Investors may also find of interest that the ETF with the largest allocation to ALNY stock is Global X Genomics & Biotechnology ETF (GNOM), with a portfolio weight of 6.02%. On average, U.S. ETFs allocate 0.54% of ALNY to their portfolios.

Additionally, ALNY is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ALNY as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 21.51%.